Adicon Holdings and Guardant Health Partner on Genomic Profiling in China
China-based Adicon Holdings Limited announced a strategic partnership with U.S. firm Guardant Health, Inc. (NASDAQ:...
Company
BeiGene and InnoRNA Partner on mRNA-LNP Therapeutic Development
China-based biotech firm BeiGene (HKG: 6160, SHA: 688235, NASDAQ: BGNE) announced a strategic partnership with...
PackGene and SineuGene Partner on ALS Gene Therapy Research
China-based PackGene has entered into another partnership with compatriot firm SineuGene. This time, the focus...
Phil Rivers Tech Raises RMB 100 Million for Computational Medicine Push
Beijing-based Phil Rivers Tech, a computational medicine-empowered drug developer, reportedly raised close to RMB 100...
Gan & Lee Pharmaceuticals Doses First Patient in GZR101 Phase I Study
China-based Gan & Lee Pharmaceuticals (SHA: 603087) announced that the first patient has been dosed...
Fosun Pharma’s FS-1502 Gets NMPA Approval for Gastric Cancer Study
China-based Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) announced that it has...
GeneScience’s Somatropin Wins NMPA Approval for Prader-Willi Syndrome
China-based Changchun GeneScience Pharmaceutical Co., Ltd announced that it has received another indication approval from...
Inmagene and HutchMed Dose First Patient in IMG-007 Global Phase I Study
China-based Inmagene Biopharmaceuticals and HutchMed (NASDAQ: HCM, HKG: 0013) announced the completion of first patient...
ClinChoice Raises USD 150M in Funding Led by Legend Capital for Expansion
Sino-US full-service Contract Research Organization (CRO) ClinChoice has reportedly raised USD 150 million in a...
Shenzhen TargetRx Raises Hundreds of Millions in Series B Financing for Drug Development
China-based Shenzhen TargetRx, Inc., a developer of small-molecule kinase inhibitors, reportedly raised “hundreds of millions”...
MabPharm’s CMAB017 Receives NMPA Approval for Clinical Study in Solid Tumors
Taizhou-based monoclonal antibody (mAb) biosimilars specialist MabPharm Ltd (HKG: 2181) announced that it has received...
Zhejiang Medicine’s NovoCodex Subsidiary Receives RMB 402M Investment
China-based Zhejiang Medicine Co., Ltd (SHA: 600216) announced that investors will inject a financial dose...
Medicilon Biomedical Plans RMB 2.16B Private Placement for R&D Expansion
China-based Shanghai Medicilon Biomedical Co., Ltd has announced plans to raise RMB 2.16 billion (USD...
Hansoh Pharmaceutical’s Generic Ibrance Approved by NMPA
China-based Hansoh Pharmaceutical Group Co., Ltd (HKG: 3692) announced that it has received market approval...
Alibaba Health’s 2022 Financial Report Shows Revenue Growth, Net Loss
China-based Alibaba Health Information Technology Ltd (HKG: 0241) released its 2022 financial report (for the...
Wuxi Biologics Set to Be Removed from US Restricted Trade List
Wuxi Biologics (HKG: 2269) is reportedly on the verge of being removed from a US...
Beijing Tianshi Tongda Raises RMB 140M for Autoimmune Disease Therapies
China-based Beijing Tianshi Tongda Pharmaceuticals Technology Co., Ltd has reportedly raised RMB 140 million (USD...
Wuhan YZY Biopharma Raises RMB 200M for Bispecific Antibodies and COVID-19 Vaccine Development
China-based Wuhan YZY Biopharma Co., Ltd has reportedly raised RMB 200 million (USD 29.8 million)...
Shandong Xinhua Pharmaceutical Inks Tech Transfer Deal for LXH-2201 with IMM
China-based Shandong Xinhua Pharmaceutical Co., Ltd (HKG: 0719) has signed a technology transfer agreement with...
InnoCare Pharma’s ICP-490 Receives NMPA Approval for Hematological Malignancies
Beijing InnoCare Pharma (HKG: 9969) announced that it has received clinical trial approval from the...